Identification of aceNKPs, a committed common progenitor population of the ILC1 and NK cell continuum.

Rodriguez-Rodriguez, Noe; Clark, Paula A; Gogoi, Mayuri; Ferreira, Ana C F; Kerscher, Bernhard; Crisp, Alastair; Jolin, Helen E; Murphy, Jane E et al. · Proc Natl Acad Sci U S A · 2022

basic_science · Level V

Where this comes from

Abstract

The development of innate lymphoid cell (ILC) transcription factor reporter mice has shown a previously unexpected complexity in ILC hematopoiesis. Using novel polychromic mice to achieve higher phenotypic resolution, we have characterized bone marrow progenitors that are committed to the group 1 ILC lineage. These common ILC1/NK cell progenitors (ILC1/NKP), which we call "aceNKPs", are defined as lineage<sup>-</sup>Id2<sup>+</sup>IL-7Rα<sup>+</sup>CD25<sup>-</sup>α4β7<sup>-</sup>NKG2A/C/E<sup>+</sup>Bcl11b<sup>-</sup>. In vitro, aceNKPs differentiate into group 1 ILCs, including NK-like cells that express Eomes without the requirement for IL-15, and produce IFN-γ and perforin upon IL-15 stimulation. Following reconstitution of <i>Rag2<sup>-/-</sup>Il2rg<sup>-/-</sup></i> hosts, aceNKPs give rise to a spectrum of mature ILC1/NK cells (regardless of their tissue location) that cannot be clearly segregated into the traditional ILC1 and NK subsets, suggesting that group 1 ILCs constitute a dynamic continuum of ILCs that can develop from a common progenitor. In addition, aceNKP-derived ILC1/NK cells effectively ameliorate tumor burden in a model of lung metastasis, where they acquired a cytotoxic NK cell phenotype. Our results identify the primary ILC1/NK progenitor that lacks ILC2 or ILC3 potential and is strictly committed to ILC1/NK cell production irrespective of tissue homing.

Medical subject headings